Stocks
Dolby Laboratories (DLB) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 465.8% | 544.9% | 439.3% | 878.7% | 878.7% | ||||
| Changes by years, y/y, % | +119pp | +79pp | -106pp | -439pp | +33.2% | ||||
Dolby Laboratories. R&D/CAPEX, %
Dolby Laboratories. R&D/CAPEX, changes, pp
Dolby Laboratories (DLB) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | LTM ? | |||
| R&D/CAPEX, % | 860.4% | 1 099% | 700.9% | 860.4% | 930.2% | 878.7% | ||
| Changes by years, y/y, % | +281pp | +206pp | -202pp | -66pp | +70pp | |||
| Changes by quarters, q/q, % | -66pp | +239pp | -398pp | +159pp | +70pp | |||
